Drugs, FDA Approval, Gene Expression and Genetic Disease

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Drugs

FDA Approval

Gene Expression

Genetic Disease

CAMP4’s funding influx paves the way for tapping regulatory RNA to treat urea cycle disorders

Pharmaceutical Technology

JULY 29, 2022

In preparation for this, drug manufacturing will begin later this year and will be outsourced to external contract manufacturing organisations (CMOs). The most common marketed drugs in this space aim to address the hyperammonaemia caused by the defective genes in this disorder. David Bumcrot PhD, CSO, CAMP4 Therapeutics.

RNA

RNA Gene Expression Gene Gene Therapy

The evolution of the RNA therapeutics landscape

Drug Discovery World

JULY 8, 2024

RNA interference: silencing gene expression The second category of RNA therapeutics is a class that has also yielded marketable drugs in recent years. These drugs, known as RNA interference (RNAi)-based therapeutics use Watson-Crick base-pairing to form an RNA helix, short duplexes of double-stranded RNA molecules.

RNA

RNA Protein Gene Expression Vaccination

Clinical Research Informer

CAMP4’s funding influx paves the way for tapping regulatory RNA to treat urea cycle disorders

The evolution of the RNA therapeutics landscape

Stay Connected